Kevin P. Kerns

Array ( [id] => 7518490 [patent_doc_number] => 07972591 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Methods for treating rheumatoid arthritis and multiple sclerosis using MCP1 fusions' [patent_app_type] => utility [patent_app_number] => 12/621228 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18341 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/972/07972591.pdf [firstpage_image] =>[orig_patent_app_number] => 12621228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253055 [patent_doc_number] => 20120157378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Methods and Compositions for Predicting a Subject\'s Susceptibility To and Risk of Developing Type 2 Diabetes' [patent_app_type] => utility [patent_app_number] => 13/125961 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19726 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157378.pdf [firstpage_image] =>[orig_patent_app_number] => 13125961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7777435 [patent_doc_number] => 20120040458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'METHOD FOR PRODUCING DENDRITIC CELLS' [patent_app_type] => utility [patent_app_number] => 13/127753 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16344 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040458.pdf [firstpage_image] =>[orig_patent_app_number] => 13127753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7518496 [patent_doc_number] => 07972597 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Methods of reducing chemotaxis using antibodies against monocyte chemotactic proteins' [patent_app_type] => utility [patent_app_number] => 12/612087 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 26534 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/972/07972597.pdf [firstpage_image] =>[orig_patent_app_number] => 12612087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171401 [patent_doc_number] => 20120107420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'METHODS OF PROGNOSIS IN CHRONIC KIDNEY DISEASE' [patent_app_type] => utility [patent_app_number] => 12/998484 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15144 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107420.pdf [firstpage_image] =>[orig_patent_app_number] => 12998484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4623808 [patent_doc_number] => 08003103 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'High affinity human antibodies to human IL-18 receptor' [patent_app_type] => utility [patent_app_number] => 12/577788 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9942 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003103.pdf [firstpage_image] =>[orig_patent_app_number] => 12577788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289920 [patent_doc_number] => 20100158913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Antibody Molecules Having Specificity for Human IL-1B' [patent_app_type] => utility [patent_app_number] => 12/569700 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12128 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 51 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158913.pdf [firstpage_image] =>[orig_patent_app_number] => 12569700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066169 [patent_doc_number] => 20110243938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Methods to Reduce B-Helper T Cells to Treat Autoimmune Diseases' [patent_app_type] => utility [patent_app_number] => 13/121680 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8764 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243938.pdf [firstpage_image] =>[orig_patent_app_number] => 13121680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6348375 [patent_doc_number] => 20100021442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'METHOD FOR PROMOTING IMMUNOTHERAPY USING AN AGENT FOR ELEVATING DENDRITIC CELL PRECURSOR LEVEL IN BLOOD' [patent_app_type] => utility [patent_app_number] => 12/554676 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9804 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021442.pdf [firstpage_image] =>[orig_patent_app_number] => 12554676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710228 [patent_doc_number] => 20120003226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'METHODS FOR TREATING OR PREVENTING IL-1BETA RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/062457 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 39445 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13062457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7713556 [patent_doc_number] => 20120005127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'METHODS FOR IMPROVEMENT OF BETA CELL FUNCTION' [patent_app_type] => utility [patent_app_number] => 13/062461 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 36621 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20120005127.pdf [firstpage_image] =>[orig_patent_app_number] => 13062461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537180 [patent_doc_number] => 20100015703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'ANTIBODY TO MAMMALIAN CYTOKINE-LIKE POLYPEPTIDE-10' [patent_app_type] => utility [patent_app_number] => 12/552239 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15761 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015703.pdf [firstpage_image] =>[orig_patent_app_number] => 12552239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600269 [patent_doc_number] => 20100098658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Biopolymer Conjugates Comprising an Interleukin-11 Analog' [patent_app_type] => utility [patent_app_number] => 12/589511 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14961 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098658.pdf [firstpage_image] =>[orig_patent_app_number] => 12589511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6544221 [patent_doc_number] => 20100016239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'HEPARIN BINDING MOTIF AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/545606 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 5487 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016239.pdf [firstpage_image] =>[orig_patent_app_number] => 12545606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062081 [patent_doc_number] => 20110200562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Chimeric Cytokine of IL-7 and Beta Chain of HGF and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/537622 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 27315 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200562.pdf [firstpage_image] =>[orig_patent_app_number] => 12537622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353395 [patent_doc_number] => 20100086560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'CHEMOKINES AS ADJUVANTS OF IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/536542 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13080 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086560.pdf [firstpage_image] =>[orig_patent_app_number] => 12536542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4520891 [patent_doc_number] => 07951360 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Mutant interleukin-2 (IL-2) polypeptides' [patent_app_type] => utility [patent_app_number] => 12/535083 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 41 [patent_no_of_words] => 18253 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951360.pdf [firstpage_image] =>[orig_patent_app_number] => 12535083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32900 [patent_doc_number] => 07785804 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Mammalian CX3C chemokine antibodies' [patent_app_type] => utility [patent_app_number] => 12/510586 [patent_app_country] => US [patent_app_date] => 2009-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23154 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785804.pdf [firstpage_image] =>[orig_patent_app_number] => 12510586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4456915 [patent_doc_number] => 07893215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Agonist antibodies to IL-23 receptor' [patent_app_type] => utility [patent_app_number] => 12/507642 [patent_app_country] => US [patent_app_date] => 2009-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13602 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/893/07893215.pdf [firstpage_image] =>[orig_patent_app_number] => 12507642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6379641 [patent_doc_number] => 20100316592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'AQUEOUS PREPARATION COMPRISING eMIP AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 12/502959 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4206 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316592.pdf [firstpage_image] =>[orig_patent_app_number] => 12502959 [rel_patent_id] =>[rel_patent_doc_number] =>)